Dexamethasone promotes DMP1 mRNA expression by inhibiting negative regulation of Runx2 in multipotential mesenchymal progenitor, ROB-C26

Cell Biology International

Volumn 32, Issue 2, 2008, Pages 239-246

  Mikami, Yoshikazu ^a   Takahashi, Tomihisa ^a   Kato, Shigeyuki ^a   Takagi, Minoru ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Dexamethasone; DMP1; Mesenchymal progenitor; MKP 1; ROB C26; Runx2

Indexed keywords

BONE SIALOPROTEIN; DENTIN MATRIX PROTEIN 1; DEXAMETHASONE; LUCIFERASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOCALCIN; SCLEROPROTEIN; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; DNA BINDING; DOWN REGULATION; MESENCHYMAL STEM CELL; NONHUMAN; OSTEOBLAST; PHOSPHORYLATION; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; CELL LINE; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DEXAMETHASONE; DUAL SPECIFICITY PHOSPHATASE 1; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMANS; MESENCHYMAL STEM CELLS; MULTIPOTENT STEM CELLS; OSTEOPONTIN; PHOSPHOPROTEINS; RATS; RECEPTORS, GLUCOCORTICOID; RNA, MESSENGER; SIALOGLYCOPROTEINS;

EID: 39549097290     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2007.08.033     Document Type: Article

References (48)

1. Atmani H., Audrain C., Mercier L., Chappard D., and Basle M.F. Phenotypic effects of continuous or discontinuous treatment with dexamethasone and/or calcitriol on osteoblasts differentiated from rat bone marrow stromal cells. J Cell Biochem 85 (2002) 640-650
2. Banerjee C., McCabe L.R., Choi J.Y., Hiebert S.W., Stein J.L., Stein G.S., et al. Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex. J Cell Biochem 66 (1997) 1-8
3. Buranasinsup S., Sila-Asna M., Bunyaratvej N., and Bunyaratvej A. In vitro osteogenesis from human skin-derived precursor cells. Dev Growth Differ 48 (2006) 263-269
4. Canalis E., and Delany A.M. Mechanisms of glucocorticoid action in bone. Ann NY Acad Sci 966 (2002) 73-81
5. Deliloglu-Gurhan S.I., Vatansever H.S., Ozdal-Kurt F., and Tuglu I. Characterization of osteoblasts derived from bone marrow stromal cells in a modified cell culture system. Acta Histochem 108 (2006) 49-57
6. D'Souza R.N., Cavender A., Sunavala G., Alvarez J., Ohshima T., Kulkarni A.B., et al. Gene expression patterns of murine dentin matrix protein 1 (Dmp1) and dentin sialophosphoprotein (DSPP) suggest distinct developmental functions in vivo. J Bone Miner Res 12 (1997) 2040-2049
7. Ducy P., Zhang R., Geoffroy V., Ridall A.L., and Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89 (1997) 747-754
8. Ducy P. CBFA1: a molecular switch in osteoblast biology. Dev Dyn 219 (2000) 461-471
9. Engelbrecht Y., de Wet H., Horsch K., Langeveldt C.R., Hough F.S., and Hulley P.A. Glucocorticoids induce rapid up-regulation of mitogen-activated protein kinase phosphatase-1 and dephosphorylation of extracellular signal-regulated kinase and impair proliferation in human and mouse osteoblast cell lines. Endocrinology 144 (2003) 412-422
10. Feng J.Q., Zhang J., Dallas S.L., Lu Y., Chen S., Tan X., et al. Dentin matrix protein 1, a target molecule for Cbfa1 in bone, is a unique bone marker gene. J Bone Miner Res 17 (2002) 1822-1831
11. Fisher L.W., Jain A., Tayback M., and Fedarko N.S. Small integrin binding ligand N-linked glycoprotein gene family expression in different cancers. Clin Cancer Res 10 (2004) 8501-8511
12. Franceschi R.T., and Xiao G. Regulation of the osteoblast-specific transcription factor, Runx2: responsiveness to multiple signal transduction pathways. J Cell Biochem 88 (2003) 446-454
13. George A., Sabsay B., Simonian P.A., and Veis A. Characterization of a novel dentin matrix acidic phosphoprotein. Implications for induction of biomineralization. J Biol Chem 268 (1993) 12624-12630
14. Gutierrez S., Javed A., Tennant D.K., van Rees M., Montecino M., Stein G.S., et al. CCAAT/enhancer-binding proteins (C/EBP) β and δ activate osteocalcin gene transcription and synergize with Runx2 at the C/EBP element to regulate bone-specific expression. J Biol Chem 277 (2002) 1316-1323
15. Harada H., Tagashira S., Fujiwara M., Ogawa S., Katsumata T., Yamaguchi A., et al. Cbfa1 isoforms exert functional differences in osteoblast differentiation. J Biol Chem 274 (1999) 6972-6978
16. He G., Dahl T., Veis A., and George A. Dentin matrix protein 1 initiates hydroxyapatite formation in vitro. Connect Tissue Res 44 Suppl. 1 (2003) 240-245
17. Hess J., Porte D., Munz C., and Angel P. AP-1 and Cbfa/runt physically interact and regulate parathyroid hormone-dependent MMP13 expression in osteoblasts through a new osteoblast-specific element 2/AP-1 composite element. J Biol Chem 276 (2001) 20029-20038
18. Hung S.C., Chang C.F., Ma H.L., Chen T.H., and Low-Tone Ho L. Gene expression profiles of early adipogenesis in human mesenchymal stem cells. Gene 340 (2004) 141-145
19. Huq N.L., Cross K.J., Ung M., and Reynolds E.C. A review of protein structure and gene organisation for proteins associated with mineralised tissue and calcium phosphate stabilisation encoded on human chromosome 4. Arch Oral Biol 50 (2005) 599-609
20. Igarashi M., Kamiya N., Hasegawa M., Kasuya T., Takahashi T., and Takagi M. Inductive effects of dexamethasone on the gene expression of Cbfa1, osterix and bone matrix proteins during differentiation of cultured primary rat osteoblasts. J Mol Histol 35 (2004) 3-10
21. Ito S., Suzuki N., Kato S., Takahashi T., and Takagi M. Glucocorticoids induce the differentiation of a mesenchymal progenitor cell line, ROB-C26 into adipocytes and osteoblasts, but fail to induce terminal osteoblast differentiation. Bone 40 (2007) 84-92
22. Karin M. New twists in gene regulation by glucocorticoid receptor: is DNA binding dispensable?. Cell 93 (1998) 487-490
23. Kassel O., Sancono A., Kratzschmar J., Kreft B., Stassen M., and Cato A.C.B. Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J 20 (2001) 7108-7116
24. Kasugai S., Todescan Jr. R., Nagata T., Yao K.L., Butler W.T., and Sodek J. Expression of bone matrix proteins associated with mineralized tissue formation by adult rat bone marrow cells in vitro: inductive effects of dexamethasone on the osteoblastic phenotype. J Cell Physiol 147 (1991) 111-112
25. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89 (1997) 755-764
26. Kulkarni G.V., Chen B., Malone J.P., Narayanan A.S., and George A. Promotion of selective cell attachment by the RGD sequence in dentine matrix protein 1. Arch Oral Biol 45 (2000) 475-484
27. Lasa M., Abraham S.M., Boucheron C., Saklatvala J., and Clark A.R. Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. Mol Cell Biol 22 (2002) 7802-7811
28. Li X., Jin L., Cui Q., Wang G.J., and Balian G. Steroid effects on osteogenesis through mesenchymal cell gene expression. Osteoporos Int 16 (2005) 101-108
29. Mazziotti G., Angeli A., Bilezikian J.P., Canalis E., and Giustina A. Glucocorticoid-induced osteoporosis: an update. Trends Endocrinol Metab 17 (2006) 144-149
30. McLarren K.W., Lo R., Grbavec D., Thirunavukkarasu K., Karsenty G., and Stifani S. The mammalian basic helix loop helix protein HES-1 binds to and modulates the transactivating function of the runt-related factor Cbfa1. J Biol Chem 275 (2000) 530-538
31. Milne M., Quail J.M., and Baran D.T. Dexamethasone stimulates osteogenic differentiation in vertebral and femoral bone marrow cell cultures: comparison of IGF-I gene expression. J Cell Biochem 71 (1998) 382-391
32. Nakashima K., Zhou X., Kunkel G., Zhang Z., Deng J.M., Behringer R.R., et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 11 (2002) 17-29
33. Narayanan K., Srinivas R., Ramachandran A., Hao J., Quinn B., and George A. Differentiation of embryonic mesenchymal cells to odontoblast-like cells by overexpression of dentin matrix protein 1. Proc Natl Acad Sci USA 98 (2001) 4516-4521
34. Narayanan K., Gajjeraman S., Ramachandran A., Hao J., and George A. Dentin matrix protein 1 regulates dentin sialophosphoprotein gene transcription during early odontoblast differentiation. J Biol Chem 281 (2006) 19064-19067
35. Ogata Y., Yamauchi M., Kim R.H., Li J.J., Freedman L.P., and Sodek J. Glucocorticoid regulation of bone sialoprotein (BSP) gene expression. Identification of a glucocorticoid response element in the bone sialoprotein gene promoter. Eur J Biochem 230 (1995) 183-192
36. Ogston N., Harrison A.J., Cheung H.F., Ashton B.A., and Hampson G. Dexamethasone and retinoic acid differentially regulate growth and differentiation in an immortalised human clonal bone marrow stromal cell line with osteoblastic characteristics. Steroids 67 (2002) 895-906
37. Pereira R.C., Delany A.M., and Canalis E. Effects of cortisol and bone morphogenetic protein-2 on stromal cell differentiation: correlation with CCAAT-enhancer binding protein expression. Bone 30 (2002) 685-691
38. Phillips J.E., Gersbach C.A., Wojtowicz A.M., and Garcia A.J. Glucocorticoid-induced osteogenesis is negatively regulated by Runx2/Cbfa1 serine phosphorylation. J Cell Sci 119 (2006) 581-591
39. Selvamurugan N., Chou W.Y., Pearman A.T., Pulumati M.R., and Partridge N.C. Parathyroid hormone regulates the rat collagenase-3 promoter in osteoblastic cells through the cooperative interaction of the activator protein-1 site and the runt domain binding sequence. J Biol Chem 273 (1998) 10647-10657
40. Shi X.M., Blair H.C., Yang X., McDonald J.M., and Cao X. Tandem repeat of C/EBP binding sites mediates PPARγ2 gene transcription in glucocorticoid-induced adipocyte differentiation. J Cell Biochem 76 (2000) 518-527
41. Shui C., Spelsberg T.C., Riggs B.L., and Khosla S. Changes in Runx2/Cbfa1 expression and activity during osteoblastic differentiation of human bone marrow stromal cells. J Bone Miner Res 18 (2003) 213-221
42. Toyosawa S., Shintani S., Fujiwara T., Ooshima T., Sato A., Ijuhin N., et al. Dentin matrix protein 1 is predominantly expressed in chicken and rat osteocytes but not in osteoblasts. J Bone Miner Res 16 (2001) 2017-2026
43. Wee H.J., Huang G., Shigesada K., and Ito Y. Serine phosphorylation of Runx2 with novel potential functions as negative regulatory mechanisms. EMBO Rep 3 (2002) 967-974
44. Wu W., Pew T., Zou M., Pang D., and Conzen S.D. Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival. J Biol Chem 280 (2005) 4117-4124
45. Xiao G., Jiang D., Gopalakrishnan R., and Franceschi R.T. Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor, Cbfa1/Runx2. J Biol Chem 277 (2002) 36181-36187
46. Yamaguchi A., and Kahn A.J. Clonal osteogenic cell lines express myogenic and adipocytic developmental potential. Calcif Tissue Int 49 (1991) 221-225
47. Zhang Y.W., Yasui N., Ito K., Huang G., Fujii M., Hanai J., et al. A RUNX2/PEBP2αA/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc Natl Acad Sci USA 97 (2000) 10549-10554
48. Zheng L., Iohara K., Ishikawa M., Into T., Takano-Yamamoto T., Matsushita K., et al. Runx3 negatively regulates Osterix expression in dental pulp cells. Biochem J 405 (2007) 69-75